AIM: To examine the association between childhood atopic dermatitis (AD) severity and family impact at baseline and after an intervention by a physician specialist, using validated measures of both severity and family impact. METHODS: Cross sectional self administered survey of parent-caregivers of 49 randomly selected children with AD; 35 parents were available for follow up. Family impact was measured using a modified AD Family Impact Scale completed by the parent-caregiver. The child's disease severity was measured using both the investigator's assessment via the Eczema Area and Severity Index (EASI) and the caregiver's assessment via the recently validated Self Assessment Eczema Area and Severity Index (SA-EASI). RESULTS: The parent-caregiver's assessment of severity of the child was the most significant correlate of the family impact of the child's AD (p = 0.65 at baseline and p = 0.38 at follow up). In multivariate regression models, the parent-caregiver's estimate of severity remained the single strongest predictor of family impact before and after receipt of dermatologist care, as well as the difference in impact between pre and post-dermatologist care. CONCLUSIONS: There is evidence to support the ability of parent-caregivers of children with AD to accurately determine severity of their child's AD; perceived severity is the driver of the family impact of this condition. Treatment of a child by a physician specialist is associated with reductions in both perceived severity, as well as family impact of this condition.
AIM: To examine the association between childhood atopic dermatitis (AD) severity and family impact at baseline and after an intervention by a physician specialist, using validated measures of both severity and family impact. METHODS: Cross sectional self administered survey of parent-caregivers of 49 randomly selected children with AD; 35 parents were available for follow up. Family impact was measured using a modified AD Family Impact Scale completed by the parent-caregiver. The child's disease severity was measured using both the investigator's assessment via the Eczema Area and Severity Index (EASI) and the caregiver's assessment via the recently validated Self Assessment Eczema Area and Severity Index (SA-EASI). RESULTS: The parent-caregiver's assessment of severity of the child was the most significant correlate of the family impact of the child's AD (p = 0.65 at baseline and p = 0.38 at follow up). In multivariate regression models, the parent-caregiver's estimate of severity remained the single strongest predictor of family impact before and after receipt of dermatologist care, as well as the difference in impact between pre and post-dermatologist care. CONCLUSIONS: There is evidence to support the ability of parent-caregivers of children with AD to accurately determine severity of their child's AD; perceived severity is the driver of the family impact of this condition. Treatment of a child by a physician specialist is associated with reductions in both perceived severity, as well as family impact of this condition.
Authors: Rajesh Balkrishnan; Michelle Naughton; Beth P Smith; Janeen Manuel; L Andrew Koman Journal: J Pediatr Health Care Date: 2002 Mar-Apr Impact factor: 1.812
Authors: Rajesh Balkrishnan; Tamara S Housman; Sarah Grummer; Stephen R Rapp; Jan Clarke; Steven R Feldman; Alan B Fleischer Journal: Pediatr Dermatol Date: 2003 Jan-Feb Impact factor: 1.588
Authors: Karin B Fieten; Wieneke T Zijlstra; Harmieke van Os-Medendorp; Yolanda Meijer; Monica Uniken Venema; Lous Rijssenbeek-Nouwens; Monique P l'Hoir; Carla A Bruijnzeel-Koomen; Suzanne G M A Pasmans Journal: Trials Date: 2014-03-26 Impact factor: 2.279
Authors: Charlotte E Rutter; Richard J Silverwood; Hywel C Williams; Philippa Ellwood; Innes Asher; Luis Garcia-Marcos; David P Strachan; Neil Pearce; Sinéad M Langan Journal: J Invest Dermatol Date: 2018-12-04 Impact factor: 8.551
Authors: T Christopher Mast; Carla DeMuro-Mercon; Claudia M Kelly; Leigh Ellen Floyd; Emmanuel B Walter Journal: BMC Pediatr Date: 2009-02-06 Impact factor: 2.125
Authors: Ana Paula Dornelles da Silva Manzoni; Magda Blessmann Weber; Aline Rodrigues da Silva Nagatomi; Rita Langie Pereira; Roberta Zaffari Townsend; Tania Ferreira Cestari Journal: An Bras Dermatol Date: 2013 Nov-Dec Impact factor: 1.896